Brickell Biotech, Inc. (BBI) Social Stream



Brickell Biotech, Inc. (BBI): $2.35

0.05 (+2.17%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

Add BBI to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#126 of 397

in industry

BRICKELL BIOTECH INC (BBI) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering BRICKELL BIOTECH INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 1 $4 $4 $4 $2.35 70.21%
2022-02-03 2 $4 $2 $3 $2.35 27.66%
2022-03-18 3 $4 $2 $3 $2.35 27.66%
2022-05-13 4 $2 $1 $1.5 $2.35 -36.17%
2022-08-16 3 $45.045 $4.5 $24.772 $2.35 954.13%

BBI reports an average of 5,317.01% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-18 1 6.00 5.000 5.500 0.741 642.24%
2021-09-20 1 6.00 5.000 5.500 0.710 674.65%
2021-11-10 1 4.00 4.000 4.000 0.352 1036.36%
2022-01-18 2 4.00 2.000 3.000 0.330 809.09%
2022-05-13 3 90.09 45.045 67.567 0.186 36226.34%

BBI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 2 0 1 0 0 3

The Trend in the Broker Recommendations


Over the past 30 weeks, BBI's average broker recommendation rating worsened by 0.67.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BBI as an investment opportunity.

  • BRICKELL BIOTECH INC's number of analysts covering the stock is higher than 92.32% of all US stocks.
  • BBI has a higher average analyst price target than 270.65% of stocks in the small market cap category.
  • BBI has a higher upside potential (average analyst target price relative to current price) than 392.13% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, BRICKELL BIOTECH INC's variance in analysts' estimates is lower than -430.79% of them.

In the Pharmaceutical Products industry, AVRO, AUTL, and AURA are the three stocks most similar to BRICKELL BIOTECH INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding BBI using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!